Grass tetany, also known as hypomagnesemia or grass staggers, is a potentially fatal metabolic condition affecting cattle and sheep that results from critically low blood magnesium levels. This condition produces dramatic neurological and neuromuscular signs including muscle tremors, incoordination, convulsions, and sudden death, making it one of the most urgent emergencies in grazing livestock operations. The neurological manifestations result from magnesium's critical role in neuromuscular function, and the condition can progress from subtle early signs to death within hours, demanding rapid recognition and treatment.
The condition primarily affects lactating cattle and sheep grazing pastures that are inherently low in magnesium or contain factors that impair magnesium absorption. Spring pastures of rapidly growing cool-season grasses present the classic high-risk scenario, but grass tetany can occur on wheat pasture, during winter feeding periods, and whenever dietary magnesium intake fails to meet the demands of lactation. The disease typically strikes animals in early to mid-lactation when magnesium demands are highest and body reserves are already depleted from the metabolic stress of peak milk production.
The economic and welfare impact of grass tetany includes both direct mortality and the broader costs of prevention programs, management modifications, and lost productivity. Case fatality rates are high, with many animals found dead without any observed prodromal signs. The loss of mature breeding females during their most productive years represents a substantial economic blow to cow-calf and sheep operations. The episodic nature of the disease, often claiming multiple animals over a short period during high-risk conditions, can be devastating to small operations and creates ongoing anxiety for producers managing cattle on tetany-prone pastures.
The treatability of grass tetany is excellent when cases are detected early, but the narrow window for successful intervention makes prevention far preferable to treatment. Intravenous magnesium administration produces rapid and often dramatic recovery in animals treated before irreversible damage occurs. However, the disease's rapid progression means that many animals die before treatment can be initiated, and even animals that receive prompt treatment may succumb if the condition is too advanced. Prevention through magnesium supplementation during high-risk periods represents the most effective approach to managing this condition.
